Stock RNAZ TRANSCODE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart TransCode Therapeutics, Inc.

Equities

RNAZ

US89357L3033

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
1.775 USD +8.23% Intraday chart for TransCode Therapeutics, Inc. -0.84% -73.07%
May. 29 TransCode Therapeutics, Inc. Reports Positive Data from First-In-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138 CI
May. 15 TransCode Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
TRANSCODE THERAPEUTICS, INC.
Bio Therapeutic Drugs
+8.23%-0.84%-73.07%-98.94% - 11.75M
Bullish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. RNAZ Stock
  4. Charts TransCode Therapeutics, Inc.
  5. Comparison Chart